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ABSTRACT  
Furuculosis is a skin infection caused by Staphylococcus aureus. It is characterised by honey crusted ‘cropped’ 
latent boil with potential to recur in a susceptible host. Isolates of S.aureus obtained from both hospitalised and 
non-hospitalised patients with furuncles in Southwest, Nigeria were characterised in relation to their resistance 
to commonly used antimicrobial agents. Exudates of ‘cropped-boils’ from one hundred and forty (140) 
individuals consisting of forty (40) hospitalised and one hundred (100) non-hospitalised cases of recurrent 
furunculosis were screened for S. aureus. One hundred and two (102) were positive for the organism by 
conventional biochemical tests. Detection of β-Iactamase was determined by cell-suspension iodometric 
method. Of the 102 isolates, 30(29.4%) strains possessed β-lactamase and the minimum inhibitory 
concentration (MIC) of selected antibiotics was in the range of 3.95– 250µg/ml. The multiple drug resistance as 
evident in high MICs of the antibiotics tested could probably be due to abuse/misuse of antibiotics resulting in 
recurrence of furuncles in the patients. 
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INTRODUCTION 
Staphylococcus aureus is a recognised human 
pathogen responsible for a great variety of pyogenic 
infection in man and animals, infecting about one-
third of the world population (Todar, 2008). The 
pathogen is also capable of living a benign lifestyle 
in the nasal passage and skin (Highet et al., 1992). It 
is the causative agent of many suppuration 
processes ranging from localised abscess which can 
occur in any part of the body, to fatal septicaemia 
and pneumonia. Furunculosis is a primary skin 
infection characterised by latent honey crusted 
‘cropped’ boil and suppuration in susceptible host. 
People with diabetes and suppressed immune 
system or acne are at great risk (Zimakoff et al., 
1988). 
 
Staphylococcus aureus isolated from furunculosis 
are drug resistant (El-Gilany and Hanan, 2009). The 
emergence of drug resistant strains isolated from 
pathogenic processes has been attributed to the 
increasing introduction of various antibiotics into 
general use (Hanan et al., 2005). Penicillin was the 
first antibiotic used for Staphylococcus infections 
and penicillin resistance appeared shortly after its 
introduction. This was followed by resistance to 
methicillin, amoxillin, tetracycline and to a lesser 
extent, erythromycin, gentamycin and other 
antibiotics (Mostafizur et al., 2005). Staphylococcus 
aureus developed intrinsic resistance to penicillins 
because of its remarkable ability to hydrolyse beta-
lactam antibiotics. The organism also has great 
ability to degrade skin lipid barrier and spread 
within skin loci (Laube and Farrell, 2002; Hoegr, 
2004). In this study, isolates of S.aureus from cases 
of furunculosis were screened for ß-lactamase 
production and the antimicrobial susceptibility of 
the isolates was investigated. 
 
*Corresponding author: Tel: +234 8058037085; E-mail: ofemilionel@yahoo.com 
Sierra Leone J Biomed Res  2011| Vol. 3 No. 3                                            www.sljbr.com 123 
 
 
MATERIALS AND METHODS 
Sample Collection and Bacterial Isolation 
A total of one hundred and forty (140) exudates of 
‘cropped’ boil from hospitalised and non-
hospitalised patients with recurrent cases of 
furunculosis were screened for the isolation of 
S.aureus on mannitol salt agar (Biotech). Suspected 
staphylococcal isolates were confirmed by catalase 
test, coagulase test, DNAse test and haemolytic test 
(Harold, 2007). Staphylococcus aureus strain ATCC 
29213 was used as reference strain. 
 
Antimicrobial Susceptibility Test 
The antimicrobial susceptibility pattern of the 
isolates was determined using method of Kirby-
Bauer (Cheesebrough, 2000). All the strains were 
tested to the following antibiotics: Cloxacilln 
(5µg/ml), Gentamicin (10µg/ml), Cotrimozaxole 
(25µg/ml), Chloramphenicol (30µg/ml), Augmentin 
(30µg/ml), Amoxicillin (25µg/ml), Erythromycin 
(5µg/ml), and Tetracycline (10µg/ml). The zones of 
inhibitions were measured with a meter rule and 
interpreted as recommended by NCCL (1998) (now 
Clinical and Laboratory Standards Institute, CLSI). 
Staphylococcus aureus ATCC 29213 was used as 
reference strain. 
 
Determination of Minimum Inhibitory 
Concentration (MIC) 
Graded decreasing double-fold concentrations of 
each antibiotic was prepared in nutrient broth and 
to each dilution was added 0.lml of a 10-2 diluted 
culture of each strain, including the standard strain. 
The tubes were incubated at 370C for 24hrs to 




Overnight pure culture of each isolate of S. aureus 
was harvested and homogenised in phosphate 
buffered penicillin G. The bacterial suspension 
measuring x107 cells/ml using MacFarland turbidity 
standard was tested for β-lactamase production by 




One hundred and two (102) haemolytic isolates 
positive for catalase test, coagulase test, mannitol 
sugar fermentation and DNAse test were selected 
for further analyses. In the antibiotic susceptibility 
testing, the percentage resistance of the isolates to 
the antibiotics used was found to be highest for 
tetracycline (55.88%) and erythromycin (43.13%), 
while resistance to Augmentin (12%) was found to 
be the lowest. Cloxacillin elicited (18.62%) 
resistance and amoxicillin, an amino acid penicillin 
was (35.29%). Cotrimoxazole, a double blocker 
antibiotics elicited 30.39% resistance while the 
organisms showed 21.56% resistance to 
chloramphenicol (Table 1). 
 
In the determination of minimum inhibitory 
concentration of selected antibiotics, the values 
obtained showed resistance of the S. aureus isolates 
to Augmentin (3.95 -250 µg/ml), Cefotaxime 
(15.63-250µg/ml), Ceftriaxone (31.25-250µg/ml), 
Penicillin (62.5-250µg/ml) and Cloxacillin (15.63-
250 µg/ml) when p-value of ˂0.05 was considered 
statistically significant (Table 2).  
 
Table 1: Antimicrobial Susceptibility Pattern of 




RESISTANCE  SUSCEPTIBLE 
   R 
  0≤5 
   S1 
5 ≤ 15 
    S2 
15 ≤ 25 
    S3 
25 ≤ 35 


































































Staphylococcus aureus is a common cause of skin 
infection and it has been isolated from 89.2-100% 
of recurrent and non-recurrent furunculosis 
patients ((Wiese-Posselt et al., 2007; El-Gilany and 
Hanan, 2009). The frequency of the pathological 
distribution of S. aureus obtained in this study 
reflects a typical prevalence pattern of the organism 
in furunculosis and corroborated the findings of 
Dahl (1987) in the strategies for management of 
recurrent furunculosis. The susceptibility of the 
organism to augmentin (amoxicillin and clavulanic 
acid) suggests the efficacy this antibiotic in the 
management of the infection. 
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Table 2: Minimum Inhibitory Concentration of the Antibiotics on Selected Strains of Staphylococcus 
aureus 
 
SA: Staphylococcus aureus; NT-Not tested; MIC: Minimum Inhibitory Concentration 
 
Unlike the report of Akindele and others who 
documented that ß-lactamase producing S. aureus 
had the highest percentage susceptibility to 
erythromycin (Akindele et al., 2010), most of the S. 
aureus examined in this study were resistant to 
tetracycline and erythromycin. This may be 
attributed to the nature of the infection and misuse 
of the antibiotics in our setting. It is not usual to 
purchase antibiotics over the counter and 
tetracycline and erythromycin are relatively 
inexpensive. Therefore, in vitro susceptibility of 
antibiotics should be ascertained before usage. 
 
 One of the major mechanisms of resistance to β-
lactams was the expression of the enzymes, beta-
lactamases such as penicillinase and 
cephalosporinase (Liang et al., 2003). High level 
beta-lactamase production was observed among 
the S.aureus tested in this study. This is consistent 
with the results of beta-lactamase production in 
S.aureus from various clinical sources in Nigeria 
(Kesah et al., 1997; Akindele et al., 2010). 
 
The range of MICs obtained for the selected 
antibiotics against the isolates of S. aureus, perhaps 
accounts for the observed recurrent furunculosis in 
this study population. The MICs obtained for 
penicillin and cefotaxime (an extended β-lactamase 
spectrum) among the resistant isolates is in 
agreement with the result of Oyelese and Oyewo 
(1995) on the menace of β –lactamase production 
on antibiotic prescription in community-acquired 
infection. Also, our report supports the analysis of 
Clewell (2008) on the threat to chemotherapeutic 
application of β-lactam antibiotics. Ninety per cent 
(90%) of the S. aureus strains gave the MICs for the 
antibiotic tested, beyond the modal MICs for the 
reference strain. Therefore, there is a need to 
institute strategies for antibiotic resistance 
surveillance to form the basis for developing and 
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implementing measures that can reduce the burden 
of infections in our setting. 
 
In conclusion, this study offers primary evidence of 
the involvement of S.aureus in the epidemiology of 
furunculosis in Nigeria. Noticeably, Staphylococcus 
aureus remains an agent of recurrent furunculosis 
and the treatment of the infection requires careful 
evaluation of the commonly available antibiotics 
especially the beta-lactams. Lack of information on 
the biodata of the patients, previous antibiotic 
usage, underlying cause of the infection and genetic 
profiling studies present limitations to this study 
and form the basis for further work. 
 
REFERENCES 
Akindele AA, Adewuyi IK, Adefioye OA, Adedokun 
SA and Olaolu AO (2010). Antibiogram and Beta-
Lactamase Production of Staphylococcus aureus 
Isolates from Different Human Clinical Specimens in 
a Tertiary Health Institution in Ile-Ife, Nigeria. 
American-Eurasian J Sci Res. 5 (4): 230-233 
 
Catlin BW (1975). Iodometric Suspension of 
Haemophilus influenza β-lactamase. Rapid 
Presumptive Test for Ampicillin and Cephalosporin 
Resistance. Antimicrob Agent Chemother. 7:265-70 
 
Cheesebrough M (2000). District Laboratory 
Practice in Tropical countries (Part 2). Cambrige 
University Press, UK. Pp: 134-143 
 
Clewell BD (2008). Antibiotic Resistance in Bacteria 
Origin and Emergence. 
http:/www/scitopics.com/antibiotic resistance in 
bacteria origins and emergence.html. [Accessed 
January, 2010] 
 
Dahl V (1987). Strategies for Management of 
Recurrent Furunculosis. South Med J. 80(3):352-6 
 
El-Gilany A and Hanan F(2009). Risk Factors of 
Recurrent Furunculosis. Dermatol Online J. 15 (1): 
16 
 
Hanan F, Eid M, Abdel-Al A and Kotb I (2005). 
Antibiotic Resistance Pattern of Staphylococcus 
aureus in Furunculosis. J Pan-Arab League of 
Dermatol. 17(1):71-81 
 
Harold JB (2007). Microbiological Applications: 
Laboratory Manual in General Microbiology. 
McGraw-Hill Higher Education, Boston. Pp: 43-57 
Highet AS, Hay RJ and Robert S (1992). Bacterial 
Infections. In: Textbook of Dermatology. Edited by 
Champion RH, Burton JL and Ebling FJG. 5th Ed. 
Blackwell Scientific Publication, Oxford. 2: 953-
1030 
 
Hoegr H (2004). Antimicrobial Susceptibility of 
Skin-colonizing Staphylococcus aureus Strains in 
Children with Atopic Dermatitis. Pediatr Allergy 
Immunol.15 (5):474-7 
 
Kesah CN, Ogunsola FT, Neemogha MT and 
Odungbemi TO (1997). An in-vitro Study of 
Methicillin and Other Antimicrobial Agent Against 
Staphylococcus aureus, 1994 -1996. Nig Qt J Hosp 
Med. 7(3): 286-88 
 
Laube S and Farrell M (2002). Bacterial Skin 
Infection in the Elderly: Diagnosis and Treatment. 
Drugs and Aging. 19(5):331-42 
 
Liang W, Huang H, Lin R and Hou W (2003). 
Screening for Natural Inhibitors of Penicillinase by 
Copolymerization of Hydrolyzed Starch or Glycogen 
in Sodium Dodecylsulfate Polyacrylamide Gels for 
Detecting Penicillinase Activity. Bot Bull  Acad Sin. 
44: 187-191 
 
Mostafizur R, Abdul HK, Shahjahan M, Dipak KP and 
Pervez H (2005). Antibiotic Susceptibility and R- 
Plasmid Mediated Drug Resistance in 
Staphylococcus aureus. Med J Islamic World Acad Sci.  
15(3)111-116 
 
National Committee for Clinical laboratory 
Standards (1998). Performance Standards for 
Antimicrobial Disk Susceptibility Test Approved 
Standard M2-A6, 8th Informational Supplement, 
National Committee for Clinical Laboratory  
Standards Wayne Pa 
 
Oyelese AO and Oyewo EA (1995). The Menace of β-
lactamase Production on Antibiotic Prescription in 
Community Acquired-infections in Nigeria. Afr J 
Med Med Sci. 24: 125-133 
 
Todar K (2008). Staphylococcus aureus and 




Wiese-Posselt M, Heuck D, Draeger A, Mielke M, 
Witte W, Ammon A and Hamouda O (2007). 
Sierra Leone J Biomed Res  2011| Vol. 3 No. 3                                            www.sljbr.com 126 
 
 
Successful Termination of a Furunculosis Outbreak 
Due to LukS-LukF-Positive, Methicillin-Susceptible 
Staphylococcus aureus in a German Village by 
Stringent Decolonization, 2002-2005. Clin Infect  
Dis. 44:e88-e95 
Zimakoff J, Rosdahl VT, Petersen W and Scheibel J 
(1988). Recurrent Staphylococcal Furunculosis in 







































Sierra Leone J Biomed Res  2011| Vol. 3 No. 3                                            www.sljbr.com 127 
